Ville Karhunen
University of Oulu
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Ville Karhunen.
International Journal of Obesity | 2018
Nicole M. Warrington; Rebecca C Richmond; Bjarke Fenstra; Ronny Myhre; Romy Gaillard; Lavinia Paternoster; Carol A. Wang; Robin N. Beaumont; Shikta Das; Mario Murcia; Sheila J. Barton; Ana Espinosa; Elisabeth Thiering; Mustafa Atalay; Niina Pitkänen; Ioanna Ntalla; Anna Jonsson; Rachel M. Freathy; Ville Karhunen; Carla M.T. Tiesler; Catherine Allard; Andrew Crawford; Susan M. Ring; Mads Melbye; Per Magnus; Fernando Rivadeneira; Line Skotte; Torben Hansen; Julie A. Marsh; Mònica Guxens
Background:Clinical recommendations to limit gestational weight gain (GWG) imply high GWG is causally related to adverse outcomes in mother or offspring, but GWG is the sum of several inter-related complex phenotypes (maternal fat deposition and vascular expansion, placenta, amniotic fluid and fetal growth). Understanding the genetic contribution to GWG could help clarify the potential effect of its different components on maternal and offspring health. Here we explore the genetic contribution to total, early and late GWG.Participants and methods:A genome-wide association study was used to identify maternal and fetal variants contributing to GWG in up to 10 543 mothers and 16 317 offspring of European origin, with replication in 10 660 mothers and 7561 offspring. Additional analyses determined the proportion of variability in GWG from maternal and fetal common genetic variants and the overlap of established genome-wide significant variants for phenotypes relevant to GWG (for example, maternal body mass index (BMI) and glucose, birth weight).Results:Approximately 20% of the variability in GWG was tagged by common maternal genetic variants, and the fetal genome made a surprisingly minor contribution to explain variation in GWG. Variants near the pregnancy-specific beta-1 glycoprotein 5 (PSG5) gene reached genome-wide significance (P=1.71 × 10−8) for total GWG in the offspring genome, but did not replicate. Some established variants associated with increased BMI, fasting glucose and type 2 diabetes were associated with lower early, and higher later GWG. Maternal variants related to higher systolic blood pressure were related to lower late GWG. Established maternal and fetal birth weight variants were largely unrelated to GWG.Conclusions:We found a modest contribution of maternal common variants to GWG and some overlap of maternal BMI, glucose and type 2 diabetes variants with GWG. These findings suggest that associations between GWG and later offspring/maternal outcomes may be due to the relationship of maternal BMI and diabetes with GWG.
Neurogastroenterology and Motility | 2017
Ferdinando Bonfiglio; Pirro G. Hysi; Weronica E. Ek; Ville Karhunen; Natalia V. Rivera; M. Männikkö; Helena Nordenstedt; Marco Zucchelli; Francesca Bresso; Frances M. K. Williams; Hans Törnblom; Patrik K. E. Magnusson; Nancy L. Pedersen; J. Ronkainen; Peter T. Schmidt; Mauro D'Amato
Gastroesophageal reflux disease (GERD), the regurgitation of gastric acids often accompanied by heartburn, affects up to 20% of the general population. Genetic predisposition is suspected from twin and family studies but gene‐hunting efforts have so far been scarce and no conclusive genome‐wide study has been reported. We exploited data available from general population samples, and studied self‐reported reflux symptoms in relation to genome‐wide single nucleotide polymorphism (SNP) genotypes.
Scientific Reports | 2018
Ang Zhou; Amy E Taylor; Ville Karhunen; Yiqiang Zhan; Suvi Rovio; Jari Lahti; Per Sjögren; Liisa Byberg; Donald M. Lyall; Juha Auvinen; Terho Lehtimäki; Mika Kähönen; Nina Hutri-Kähönen; Mia Maria Perälä; Karl Michaëlsson; Anubha Mahajan; Lars Lind; Chris Power; Johan G. Eriksson; Olli T. Raitakari; Sara Hägg; Nancy L. Pedersen; Juha Veijola; Marjo-Riitta Järvelin; Marcus R. Munafò; Erik Ingelsson; David J. Llewellyn; Elina Hyppönen
Coffee’s long-term effect on cognitive function remains unclear with studies suggesting both benefits and adverse effects. We used Mendelian randomization to investigate the causal relationship between habitual coffee consumption and cognitive function in mid- to later life. This included up to 415,530 participants and 300,760 coffee drinkers from 10 meta-analysed European ancestry cohorts. In each cohort, composite cognitive scores that capture global cognition and memory were computed using available tests. A genetic score derived using CYP1A1/2 (rs2472297) and AHR (rs6968865) was chosen as a proxy for habitual coffee consumption. Null associations were observed when examining the associations of the genetic score with global and memory cognition (β = −0.0007, 95% C.I. −0.009 to 0.008, P = 0.87; β = −0.001, 95% C.I. −0.005 to 0.002, P = 0.51, respectively), with high consistency between studies (Pheterogeneity > 0.4 for both). Domain specific analyses using available cognitive measures in the UK Biobank also did not support effects by habitual coffee intake for reaction time, pairs matching, reasoning or prospective memory (P ≥ 0.05 for all). Despite the power to detect very small effects, our meta-analysis provided no evidence for causal long-term effects of habitual coffee consumption on global cognition or memory.
Neurogastroenterology and Motility | 2018
Ferdinando Bonfiglio; Maria Henström; Abhishek Nag; Fatemeh Hadizadeh; T. Zheng; M. C. Cenit; Ettje F. Tigchelaar; Frances M. K. Williams; A. Reznichenko; Weronica E. Ek; Natalia V. Rivera; Georg Homuth; Ali Aghdassi; Tim Kacprowski; M. Männikkö; Ville Karhunen; L. Bujanda; J. Rafter; Cisca Wijmenga; J. Ronkainen; Pirro G. Hysi; Alexandra Zhernakova; Mauro D'Amato
Irritable bowel syndrome (IBS) shows genetic predisposition, however, large‐scale, powered gene mapping studies are lacking. We sought to exploit existing genetic (genotype) and epidemiological (questionnaire) data from a series of population‐based cohorts for IBS genome‐wide association studies (GWAS) and their meta‐analysis.
Journal of Medical Genetics | 2018
William Schierding; Jisha Antony; Ville Karhunen; Marja Vääräsmäki; S. Franks; Paul Elliott; Eero Kajantie; Sylvain Sebert; Alex Blakemore; Julia A. Horsfield; Marjo-Riitta Järvelin; Justin M. O’Sullivan; Wayne S. Cutfield
Background Gestation is a crucial timepoint in human development. Deviation from a term gestational age correlates with both acute and long-term adverse health effects for the child. Both being born preterm and post-term, that is, having short and long gestational ages, are heritable and influenced by the prenatal and perinatal environment. Despite the obvious heritable component, specific genetic influences underlying differences in gestational age are poorly understood. Methods We investigated the genetic architecture of gestational age in 9141 individuals, including 1167 born post-term, across two Northern Finland cohorts born in 1966 or 1986. Results Here we identify one globally significant intronic genetic variant within the ADAMTS13 gene that is associated with prolonged gestation (p=4.85×10−8). Additional variants that reached suggestive levels of significance were identified within introns at the ARGHAP42 and TKT genes, and in the upstream (5’) intergenic regions of the B3GALT5 and SSBP2 genes. The variants near the ADAMTS13, B3GALT5, SSBP2 and TKT loci are linked to alterations in gene expression levels (cis-eQTLs). Luciferase assays confirmed the allele specific enhancer activity for the BGALT5 and TKT loci. Conclusions Our findings provide the first evidence of a specific genetic influence associated with prolonged gestation. This study forms a foundation for a better understanding of the genetic and long-term health risks faced by induced and post-term individuals. The long-term risks for induced individuals who have a previously overlooked post-term potential may be a major issue for current health providers.
International Journal of Obesity | 2018
Estelle Lowry; Nina Rautio; Ville Karhunen; Jouko Miettunen; Leena Ala-Mursula; Juha Auvinen; Sirkka Keinänen-Kiukaanniemi; Katri Puukka; Inga Prokopenko; Karl-Heinz Herzig; Alexandra M. Lewin; Sylvain Sebert; Marjo-Riitta Järvelin
BackgroundThe prevention of the risk of type 2 diabetes (T2D) is complicated by multidimensional interplays between biological and psychosocial factors acting at the individual level. To address the challenge we took a systematic approach, to explore the bio-psychosocial predictors of blood glucose in mid-age.MethodsBased on the 31-year and 46-year follow-ups (5,078 participants, 43% male) of Northern Finland Birth Cohort 1966, we used a systematic strategy to select bio-psychosocial variables at 31 years to enable a data-driven approach. As selection criteria, the variable must be (i) a component of the metabolic syndrome or an indicator of psychosocial health using WHO guidelines, (ii) easily obtainable in general health check-ups and (iii) associated with fasting blood glucose at 46 years (P < 0.10). Exploratory and confirmatory factor analysis were used to derive latent factors, and stepwise linear regression allowed exploration of relationships between factors and fasting glucose.ResultsOf all 26 variables originally considered, 19 met the selection criteria and were included in an exploratory factor analysis. Two variables were further excluded due to low loading (<0.3). We derived four latent factors, which we named as socioeconomic, metabolic, psychosocial and blood pressure status. The combination of metabolic and psychosocial factors, adjusted for sex, provided best prediction of fasting glucose at 46 years (explaining 10.7% of variation in glucose; P < 0.001). Regarding different bio-psychosocial pathways and relationships, the importance of psychosocial factors in addition to established metabolic risk factors was highlighted.ConclusionsThe present study supports evidence for the bio-psychosocial nature of adult glycemic health and exemplifies an evidence-based approach to model the bio-psychosocial relationships. The factorial model may help further research and public health practice in focusing also on psychosocial aspects in maintaining normoglycaemia in the prevention of cardio-metabolic diseases.
bioRxiv | 2018
Petri Wiklund; Ville Karhunen; Rebecca C Richmond; Alina Rodriguez; Maneka De Silva; Matthias Wielscher; Faisal I. Rezwan; Tom G. Richardson; Juha Veijola; Karl Heinz-Herzig; John W. Holloway; Caroline L Relton; Sylvain Sebert; Marjo-Riitta Järvelin
Maternal smoking during pregnancy is associated with adverse offspring health outcomes across their life course. We hypothesize that DNA methylation is a potential mediator of this relationship. To test this, we examined the association of prenatal maternal smoking with DNA methylation in 2,821 individuals (age 16 to 48 years) from five prospective birth cohort studies and perform Mendelian randomization and mediation analyses to assess, whether methylation markers have causal effects on disease outcomes in the offspring. We identify 69 differentially methylated CpGs in 36 genomic regions (P < 1×10−7), and show that DNA methylation may represent a biological mechanism through which maternal smoking is associated with increased risk of psychiatric morbidity in the exposed offspring.
bioRxiv | 2018
Richard Karlsson Linner; Pietro Biroli; Edward Kong; S. Fleur W. Meddens; Robbee Wedow; Mark Alan Fontana; Mael Lebreton; Abdel Abdellaoui; Anke R. Hammerschlag; Michel G. Nivard; Aysu Okbay; Cornelius A. Rietveld; Pascal Timshel; Stephen P Tino; Maciej Trzaskowski; Ronald de Vlaming; Christian L Zünd; Yanchun Bao; Laura Buzdugan; Ann H Caplin; Chia-Yen Chen; Peter Eibich; Pierre Fontanillas; Juan R. González; Peter K. Joshi; Ville Karhunen; Aaron Kleinman; Remy Z Levin; Christina M. Lill; Gerardus A. Meddens
Humans vary substantially in their willingness to take risks. In a combined sample of over one million individuals, we conducted genome-wide association studies (GWAS) of general risk tolerance, adventurousness, and risky behaviors in the driving, drinking, smoking, and sexual domains. We identified 611 approximately independent genetic loci associated with at least one of our phenotypes, including 124 with general risk tolerance. We report evidence of substantial shared genetic influences across general risk tolerance and risky behaviors: 72 of the 124 general risk tolerance loci contain a lead SNP for at least one of our other GWAS, and general risk tolerance is moderately to strongly genetically correlated ( to 0.50) with a range of risky behaviors. Bioinformatics analyses imply that genes near general-risk-tolerance-associated SNPs are highly expressed in brain tissues and point to a role for glutamatergic and GABAergic neurotransmission. We find no evidence of enrichment for genes previously hypothesized to relate to risk tolerance.Humans vary substantially in their willingness to take risks. In a combined sample of over one million individuals, we conducted genome-wide association studies (GWAS) of general risk tolerance, adventurousness, and risky behaviors in the driving, drinking, smoking, and sexual domains. We identified 611 approximately independent genetic loci associated with at least one of our phenotypes, including 124 with general risk tolerance. We report evidence of substantial shared genetic influences across general risk tolerance and risky behaviors: 72 of the 124 general risk tolerance loci contain a lead SNP for at least one of our other GWAS, and general risk tolerance is moderately to strongly genetically correlated (|rˆ g | ~ 0.25 to 0.50) with a range of risky behaviors. Bioinformatics analyses imply that genes near general-risk-tolerance-associated SNPs are highly expressed in brain tissues and point to a role for glutamatergic and GABAergic neurotransmission. We find no evidence of enrichment for genes previously hypothesized to relate to risk tolerance.
PLOS ONE | 2018
Sarah Metrustry; Ville Karhunen; Mark H. Edwards; Cristina Menni; Thomas Geisendorfer; Anja Huber; Christian Reichel; Elaine M. Dennison; C Cooper; Tim D. Spector; Marjo-Riitta Järvelin; Ana M. Valdes
Several studies suggest that low birthweight resulting from restricted intrauterine growth can leave a metabolic footprint which may persist into adulthood. To investigate this, we performed metabolomic profiling on 5036 female twins, aged 18–80, with weight at birth information available from the TwinsUK cohort and performed independent replication in two additional cohorts. Out of 422 compounds tested, 25 metabolites associated with birthweight in these twins, replicated in 1951 men and women from the Hertfordshire Cohort Study (HCS, aged 66) and in 2391 men and women from the North Finland Birth 1986 cohort (NFBC, aged 16). We found distinct heterogeneity between sexes and, after adjusting for multiple tests and heterogeneity, two metabolites were reproducible overall (propionylcarnitine and 3-4-hydroxyphenyllactate). Testing women only, we found other metabolites associated with lower birthweight from the meta-analysis of the three cohorts (2-hydroxy-butyric acid and γ-glutamylleucine). Higher levels of all these metabolites can be linked to insulin resistance, oxidative stress or a dysfunction of energy metabolism, suggesting that low birthweight in both twins and singletons are having an impact on these pathways in adulthood.
bioRxiv | 2017
William Schierding; Jisha Antony; Ville Karhunen; Marja Vääräsmäki; S. Franks; Paul Elliot; Eero Kajantie; Sylvian Sebert; Alex Blakemore; Julia A. Horsfield; Marjo-Ritta Järvelin; Justin M. O'Sullivan; Wayne S. Cutfield
Gestation is a crucial timepoint in human development. Deviation from a term gestational age correlates with both acute and long-term adverse health effects for the child. Both being born pre and post-term, i.e. having short and long gestational ages, are heritable and influenced by the pre- and perinatal environment. Despite the obvious heritable component, specific genetic influences underlying differences in gestational age are poorly understood. Here we identify one globally significant intronic genetic variant within the ADAMTS13 gene that is associated with prolonged gestation in 9,141 white European individuals from the 1966 and 1986 Northern Finland birth cohorts. Additional variants that reached suggestive levels of significance were identified within introns at the TKT, and ARGHAP42 genes, and in the upstream (5’) intergenic regions of the B3GALT5 and SSBP2 genes. The variants near the ADAMTS13, B3GALT5, SSBP2 and TKT loci are linked to alterations in gene expression levels (cis-eQTLs). Luciferase assays confirmed the allele specific enhancer activity for the BGALT5 and TKT loci. Our findings provide the first evidence of a specific genetic influence associated with prolonged gestation.